StockpollyBeta
Get App
Popularity #2,397
BHC · NYSE · Drug Manufacturers - Specialty & Generic

Bausch Health (BHC)

Sells specialty medicines, medical devices and eye-health products through Bausch + Lomb.

$5.80
After hours−0.00 (−0.09%)
At close$5.81(+2.93%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue2,2382,4082,1532,4032,5102,5592,2592,5302,6812,7962,5242,852
Cost of revenue623705640719696727701764750798738772
Gross profit1,6151,7031,5131,6841,8141,8321,5581,7661,9311,9981,7862,080
1,6011,3411,2321,2951,4961,2741,2661,3091,2951,1691,2651,305
Research & development15315215115916116314315924751163173
715762789832850816867894795882861907
Selling & marketing0625000786000000
General & administrative013700030000000
Other expenses733427292304485295256256253236241225
Operating income14362281389318558292457636829521775
−340−369−350−341−339−349−339−317−418−773−1,875−427
Interest income67987911131591011
Interest expense339363355350346337330465412397402396
Other non-operating income−480−145−18−37−226−369−14863761,47331
Income before tax−326−7−6948−21209−4714021856−1,354348
Income tax expense5640849711113912371597788
Net income from continuing operations−382−47−77−1−9298−86128181−103−1,431260
Net income−378−39−6410−8593−58148179−112−1,423258
EPS, basic−$1.03−$0.11−$0.17$0.03−$0.23$0.25−$0.16$0.41$0.48−$0.31−$3.79$0.67
EPS, diluted−$1.03−$0.11−$0.17$0.03−$0.23$0.25−$0.16$0.40$0.47−$0.31−$3.79$0.68
Weighted average shares, basic365365367368368372370371371371373375
Weighted average shares, diluted365365367370368372370373376371373378
EBITDA795836619744866901588912936743−6571,025
Depreciation & amortization301329320318322307305307306290295281
EBIT494507299426544594283605630453−952744